Type 2 endometrial cancer is the latest hormone related cancer to be associated with HSD3B1, according to a study in JNCI Cancer Spectrum. This research may help scientists predict and treat disease.
Research published in the Journal of the National Cancer Institute indicates that men with advanced prostate cancer who are prescribed abiraterone and enzalutamide may have an increased risk of metabolic and cardiovascular problems.
A new study under review in the European Journal of Human Genetics indicates that abdominal obesity could be associated with an increased risk of developing pancreatic cancer.
American scientists have deciphered the signalling pathway that regulates a key enzyme implicated in causing mutations that result in normal adrenal cells becoming cancerous, as published in Cell Reports.
A new study, published in Diabetologia, indicates that prostasin may be a marker for identifying patients at greater risk of developing diabetes or cancer.
American researchers have published a paper in Journal of the American Medical Association Oncology which indicates a positive association between cancer incidence and higher insulin doses in patients with type 1 diabetes.
Results of a mouse study published in Nature has detected a link between exposure to cold conditions and inhibition of solid tumour growth, which could provide a new approach for cancer therapy.